-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on ORIC Pharmaceuticals, Raises Price Target to $18

Benzinga·10/26/2026 16:44:11
Listen to the news
Stifel analyst Laura Prendergast maintains ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy and raises the price target from $14 to $18.